Feedback / Questions
camidanlumab tesirine (ADCT-301) - Genmab, ADC Therapeutics
Keytruda (pembrolizumab) - Merck (MSD)
https://www.researchtopractice.com/Meetings/FSS2023/Part1/Lymphoma
Oct 22, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next